مؤسسة الشرق الأوسط للنشر العلمي
عادةً ما يتم الرد في غضون خمس دقائق
Chronic Kidney Disease (CKD) is a significant global health challenge, with anemia being one of its most common complications. Inflammation has been identified as a key factor that exacerbates the severity of anemia in CKD through mechanisms such as impaired iron metabolism, increased hepcidin production, and reduced responsiveness to erythropoiesis-stimulating agents (ESAs). This paper provides a comprehensive review of the role of inflammation in the progression of anemia in CKD patients, highlighting key inflammatory markers and mechanisms. By synthesizing findings from recent studies, it emphasizes the need for targeted anti-inflammatory strategies to improve anemia outcomes in CKD patients.